✦ LIBER ✦

No reduction in cardiovascular risk with NSAIDs—including aspirin?

✍ Scribed by John GF Cleland

Book ID: 117279540
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 53 KB
Volume: 359
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)07332-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risks versus Benefits of NSAIDs Includin

Risks versus Benefits of NSAIDs Including Aspirin in Myocarditis

✍ Dr Christophe Meune, Christian Spaulding, Isabelle Mahé, Pierre Lebon, Jean-Fran 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 97 KB

No Obvious Extra Cardiovascular Risk Ass

No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs

✍ Moore, N 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

PCV72 UTILIZATION PATTERNS OF ASPIRIN AM

PCV72 UTILIZATION PATTERNS OF ASPIRIN AMONG NSAID TREATED SUBJECTS WITH VARYING CARDIOVASCULAR RISK PROFILES IN A HEALTH BENEFITS POPULATION

✍ PR Vanderpoel; JN Stacy; MA Hussein; AW Bakst 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Implementing Cardiovascular Risk Reducti

Implementing Cardiovascular Risk Reduction in Patients with Cardiovascular Disease and Diabetes Mellitus

✍ Shailesh Nandish; Jamison Wyatt; Oscar Bailon; Mike Smith; Rene Oliveros; Robert 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Study shows no increase in CV risk with

Study shows no increase in CV risk with COX-2s vs NSAIDs

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Maintenance of Cardiovascular Risk Goals

Maintenance of Cardiovascular Risk Goals in Veterans With Diabetes After Discharge from a Cardiovascular Risk Reduction Clinic

✍ Paul A. Pirraglia; Tracey H. Taveira; Lisa B. Cohen; Andrea Dooley; Wen-Chih Wu 📂 Article 📅 2009 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 205 KB